Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study - 22/04/20
Doi : 10.1016/j.jaad.2020.01.084
Alexandra Fisch, MD a, Lucas Morin, PhD b, c, Toomas Talme, MD, PhD d, Kristina Johnell, MScPharm, PhD b, c, Irène Gallais Sérézal, MD, PhD d, e, ⁎ 
a Department of Dermatology, Gävle Hospital, Gävle, Sweden
b Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
c Institut National de la Santé et de la Recherche Médicale 1431 Centre d'Investigation Clinique, University Hospital Besançon, Besançon, France
d Department of Dermatology and Venerology, Karolinska University Hospital, Stockholm, Sweden
e Department of Dermatology, Besançon University Hospital, Besançon, France
∗Correspondence to: Irène Gallais Sérézal, Department of Dermatovenerology, Karolinska University Hospital, 171 24 Stockholm, SwedenDepartment of DermatovenerologyKarolinska University HospitalStockholm171 24Sweden
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Wednesday 22 April 2020
Graphical abstract |
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Supplemental material available at 2. |
|
| IRB approval status: Approved by Stockholm Regional Committee of Ethics (DNR 2017/897-31/4). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?